Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (141-150 of 497) with videos related to

Pageof 50
Sort By:
Tumori|August 29, 2019
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancerGiulia Galli, Claudia Proto, Mara Cossa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2007
Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug developmentGiuseppe Curigliano, Gianluca Spitaleri, Howard J Fingert, et al.
ESMO Open|November 7, 2020
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT studyFederico Nichetti, Marta Bini, Margherita Ambrosini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancerTommaso De Pas, Gianluca Spitaleri, Giuseppe Pelosi, et al.
International Journal of Surgical Pathology|March 15, 2013
ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterizationGiuseppe Pelosi, Giulio Rossi, Alberto Cavazza, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Breast Cancer Research : BCR|April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implicationsClaudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lungGiulia Veronesi, Giuseppe Pelosi, Angelica Sonzogni, et al.
Tumori|March 9, 2022
Paraneoplastic neurological syndromes in patients affected by SCLC: a case seriesCaterina Zanella, Alberto Giovanni Leone, Luca Zambelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2005
Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity studyGianpiero Catalano, Barbara Alicija Jereczek-Fossa, Tommaso De Pas, et al.
Pageof 50

Showing results (141-150 of 497) with videos related to

Sort By:
Pageof 50
Tumori|August 29, 2019
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancerGiulia Galli, Claudia Proto, Mara Cossa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2007
Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug developmentGiuseppe Curigliano, Gianluca Spitaleri, Howard J Fingert, et al.
ESMO Open|November 7, 2020
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT studyFederico Nichetti, Marta Bini, Margherita Ambrosini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancerTommaso De Pas, Gianluca Spitaleri, Giuseppe Pelosi, et al.
International Journal of Surgical Pathology|March 15, 2013
ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterizationGiuseppe Pelosi, Giulio Rossi, Alberto Cavazza, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Breast Cancer Research : BCR|April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implicationsClaudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lungGiulia Veronesi, Giuseppe Pelosi, Angelica Sonzogni, et al.
Tumori|March 9, 2022
Paraneoplastic neurological syndromes in patients affected by SCLC: a case seriesCaterina Zanella, Alberto Giovanni Leone, Luca Zambelli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2005
Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity studyGianpiero Catalano, Barbara Alicija Jereczek-Fossa, Tommaso De Pas, et al.
Pageof 50